SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Clinical trials for SYSTEMIC LIGHT CHAIN AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LIGHT CHAIN AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC LIGHT CHAIN AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat amyloidosis
Disease control Recruiting nowThis study is testing an investigational drug called TQB2934 for people with systemic light chain amyloidosis that has come back or stopped responding to prior treatments. The main goals are to find a safe and effective dose and to see if the drug can help clear the harmful prote…
Matched conditions: SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for amyloidosis patients: experimental antibody therapy trial opens
Disease control Recruiting nowThis study is testing a new antibody treatment called CM336 for people newly diagnosed with systemic light chain amyloidosis, a serious disease where abnormal proteins build up in organs. The trial will enroll 21 participants at a single hospital in China to see how well the trea…
Matched conditions: SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC